Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer: Relating 33 Years of Patient Clinical Care

JAMA Oncol. 2016 May 1;2(5):686. doi: 10.1001/jamaoncol.2016.0367.
No abstract available

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgens / metabolism*
  • Anilides / adverse effects
  • Drug-Related Side Effects and Adverse Reactions / physiopathology*
  • Flutamide / adverse effects
  • Gonadotropin-Releasing Hormone / agonists
  • Humans
  • Leuprolide / adverse effects
  • Libido / drug effects
  • Male
  • Medicare
  • Neoplasm Metastasis
  • Nitriles / adverse effects
  • Penis / drug effects
  • Penis / physiopathology
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / physiopathology*
  • Tosyl Compounds / adverse effects
  • United States

Substances

  • Androgen Antagonists
  • Androgens
  • Anilides
  • Nitriles
  • Tosyl Compounds
  • Gonadotropin-Releasing Hormone
  • Flutamide
  • bicalutamide
  • Leuprolide